{"id":69013,"date":"2026-03-13T11:58:53","date_gmt":"2026-03-13T11:58:53","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=69013"},"modified":"2026-10-15T10:33:59","modified_gmt":"2026-10-15T10:33:59","slug":"kpv-lysine-proline-valine","status":"publish","type":"product","link":"https:\/\/medsbase.com\/es\/product\/kpv-lysine-proline-valine\/","title":{"rendered":"KPV (Lisina-Prolina-Valina)"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Respuesta r\u00e1pida \u2014 \u00bfQu\u00e9 es KPV?<\/h3>\n<p style=\"margin: 0;\"><strong>KPV<\/strong> es el trip\u00e9ptido Lys-Pro-Val \u2014 el fragmento C-terminal antiinflamatorio de la hormona estimulante de melanocitos alfa (\u03b1-MSH). A diferencia de los an\u00e1logos m\u00e1s amplios de melanocortina, KPV <strong>no tiene actividad pigmentaria<\/strong>; its signal is purely anti-inflammatory via NFkB inhibition and mast-cell stabilization. Studied for IBD, allergic inflammation, and skin-inflammation studies. Supplied in 5\u00a0mg and 10\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Qu\u00e9 obtienes con MedsBase:<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/es\/reviews\/\">opiniones de clientes<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Cada pedido est\u00e1 cubierto por nuestra <a href=\"https:\/\/medsbase.com\/es\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> \u2014 si tu paquete no llega en 20 d\u00edas laborables, lo reenviamos.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Especificaci\u00f3n<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detalle<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>N\u00famero CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">67727-97-3<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>F\u00f3rmula molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>16<\/sub>H<sub>30<\/sub>N<sub>4<\/sub>O<sub>4<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Peso molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">342.43 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Secuencia<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lys-Pro-Val (\u03b1-MSH 11\u201313)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forma<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Polvo liofilizado (o seg\u00fan suministro)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Pureza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (verificado por HPLC, COA bajo solicitud)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Almacenamiento<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Liofilizado: 2\u20138 \u00b0C (refrigerador) para stock de trabajo; \u221220 \u00b0C para almacenamiento a largo plazo de viales sin abrir. Reconstituido: 2\u20138 \u00b0C, usar dentro de ~30 d\u00edas. Proteger de la luz. No congelar-descongelar la soluci\u00f3n reconstituida.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilidad<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Agua bacteriost\u00e1tica (recomendada) o agua est\u00e9ril para periodos de uso m\u00e1s cortos<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>\u00bfQu\u00e9 es KPV?<\/h2>\n<p><strong>KPV<\/strong> es la abreviatura en c\u00f3digo de una letra para el <strong>trip\u00e9ptido Lys-Pro-Val<\/strong> \u2014 the C-terminal three amino acids (positions 11\u201313) of alpha-melanocyte stimulating hormone (\u03b1-MSH). In the 1980s\u20131990s, multiple groups noticed that the full \u03b1-MSH molecule produced two functionally separable effects: the well-known N-terminal MC-receptor pigmentation\/arousal activity, and a C-terminal <strong>antiinflamatoria<\/strong> activity. When the C-terminal KPV tripeptide was synthesised and tested in isolation, it reproduced the anti-inflammatory effects without the pigmentation side-effects. Molecular weight approximately 342.4\u00a0Da. KPV is one of the smallest peptides in the melanocortin family and one of the most-studied anti-inflammatory studies tripeptides. It is supplied as a high-purity lyophilized powder. For mechanism, IBD studies history, and stacking context, see our <a href=\"https:\/\/medsbase.com\/es\/kpv-peptide-anti-inflammatory-guide\/\">KPV guide<\/a>. <\/p>\n<h2>Mecanismo de acci\u00f3n \u2014 Tres v\u00edas antiinflamatorias<\/h2>\n<p>La actividad antiinflamatoria de KPV opera a trav\u00e9s de al menos tres v\u00edas complementarias, todas las cuales convergen en la reducci\u00f3n de la se\u00f1alizaci\u00f3n inflamatoria sin afectar otras funciones de las melanocortinas:<\/p>\n<ul>\n<li><strong>Inhibici\u00f3n de NFkB<\/strong> \u2014 KPV bloquea la translocaci\u00f3n de NFkB al n\u00facleo, impidiendo la transcripci\u00f3n de citocinas proinflamatorias como TNF-alfa, IL-6, IL-1\u03b2 e IL-8. NFkB es el regulador maestro de la expresi\u00f3n g\u00e9nica inflamatoria, por lo que bloquear su activaci\u00f3n produce un amplio efecto antiinflamatorio aguas arriba.<\/li>\n<li><strong>Estabilizaci\u00f3n de mastocitos<\/strong> \u2014 KPV reduces mast-cell degranulation and histamine release in study models. This is a distinct mechanism from NFkB inhibition and is particularly relevant to allergic-inflammation studies and topical skin-inflammation models.<\/li>\n<li><strong>Separaci\u00f3n p\u00e9ptido-vs-MSH<\/strong> \u2014 dado que KPV es solo el fragmento C-terminal, <strong>no activa MC1R<\/strong> (el receptor de pigmentaci\u00f3n) ni MC4R (el receptor de activaci\u00f3n\/alimentaci\u00f3n). Esto separa mec\u00e1nicamente la actividad antiinflamatoria de otros efectos de la \u03b1-MSH \u2014 a diferencia de an\u00e1logos m\u00e1s amplios de MC como <a href=\"https:\/\/medsbase.com\/es\/melanotan-ii\/\">Melanotan II<\/a> o <a href=\"https:\/\/medsbase.com\/es\/pt-141\/\">PT-141<\/a>.<\/li>\n<\/ul>\n<p>The practical studies implication: KPV is a &#8220;clean&#8221; anti-inflammatory tool that produces the \u03b1-MSH anti-inflammatory signal without the tanning, arousal, or appetite-modulation effects that complicate interpretation of studies using full-length MC agonists. <\/p>\n<h2>Published Evidence<\/h2>\n<p>KPV is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>IBD and colitis studies<\/strong> \u2014 inflammatory bowel disease rodent models; KPV is active via both SC and oral routes, making it unusually flexible for GI-inflammation studies (Brzoska et al., Endocr Rev 2008)<\/li>\n<li><strong>Inflamaci\u00f3n al\u00e9rgica<\/strong> \u2014 mast-cell stabilization and histamine-release studies in allergy and atopy models<\/li>\n<li><strong>Inflamaci\u00f3n cut\u00e1nea<\/strong> \u2014 eczema, psoriasis, and contact-dermatitis study models; topical formulations appear in some protocols<\/li>\n<li><strong>Cicatrizaci\u00f3n de heridas<\/strong> \u2014 anti-inflammatory phase of wound-healing studies, often paired with <a href=\"https:\/\/medsbase.com\/es\/bpc-157\/\">BPC-157<\/a> para cobertura combinada antiinflamatoria y de factores de crecimiento<\/li>\n<li><strong>Inflamaci\u00f3n articular<\/strong> \u2014 arthritis and joint-inflammation rodent study models<\/li>\n<li><strong>Stacking studies<\/strong> \u2014 com\u00fanmente combinado con <a href=\"https:\/\/medsbase.com\/es\/bpc-157\/\">BPC-157<\/a> in GI and connective-tissue studies where anti-inflammatory + tissue-repair coverage is needed<\/li>\n<li><strong>Melanocortin comparative studies<\/strong> \u2014 en comparaci\u00f3n directa con <a href=\"https:\/\/medsbase.com\/es\/melanotan-ii\/\">Melanotan II<\/a> y <a href=\"https:\/\/medsbase.com\/es\/pt-141\/\">PT-141<\/a> para aislar los efectos puramente antiinflamatorios frente a los efectos del receptor MC<\/li>\n<\/ul>\n<p>Para un contexto m\u00e1s amplio sobre p\u00e9ptidos antiinflamatorios y curativos, consulte <a href=\"https:\/\/medsbase.com\/es\/peptides\/\">cat\u00e1logo de p\u00e9ptidos<\/a>. <\/p>\n<h2>Concentraciones y potencias disponibles<\/h2>\n<p>MedsBase ofrece KPV en los siguientes tama\u00f1os de viales liofilizados:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Potencia del vial<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Caso de uso t\u00edpico<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Tama\u00f1os de paquete<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Short protocols, pilot dosing \u2014 supports ~10 administrations at 500 mcg<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 viales<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength \u2014 supports ~20 administrations at 500 mcg<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 viales<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>KPV protocols span a range depending on model system \u2014 200\u2013500\u00a0mcg SC daily for systemic anti-inflammatory studies, or topical\/oral routes for GI and skin contexts. All strengths are supplied as lyophilized powder at 99%+ HPLC purity. <\/p>\n<h2>C\u00f3mo se compara \u2014 KPV frente a otros p\u00e9ptidos antiinflamatorios\/melanocortinas<\/h2>\n<p>KPV is one of the cleanest anti-inflammatory peptides in use because its activity is so narrow. Compared to related compounds:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Criterio<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">KPV<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">BPC-157<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Melanotan II<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Longitud<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">3 amino\u00e1cidos<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">15 amino\u00e1cidos<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">7 amino\u00e1cidos (c\u00edclicos)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Actividad principal<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Solo antiinflamatorio<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Antiinflamatorio + reparaci\u00f3n tisular + receptor GH<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Agonista amplio de MC (MC1-5)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Actividad de receptor MC<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Ninguna (solo C-terminal)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Ninguno<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">MC1, MC3, MC4, MC5<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Efecto sobre la pigmentaci\u00f3n<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Ninguno<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Ninguno<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Fuerte (se\u00f1al primaria)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Study applications<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">EII, alergia, inflamaci\u00f3n cut\u00e1nea<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Recuperaci\u00f3n de tend\u00f3n, intestino, m\u00fasculo<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Melanog\u00e9nesis, fotoprotecci\u00f3n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For GI-inflammation studies, KPV + BPC-157 is a particularly common combination because KPV provides upstream anti-inflammatory signaling while BPC-157 provides tissue-repair growth-factor activity. This is covered in our <a href=\"https:\/\/medsbase.com\/es\/bpc-157-peptide-healing-recovery-guide\/\">BPC-157 guide<\/a>. <\/p>\n<h2>Almacenamiento y reconstituci\u00f3n<\/h2>\n<p><strong>Antes de la reconstituci\u00f3n:<\/strong> almacene los viales liofilizados refrigerados a 2\u20138 \u00b0C en su envase original, estables hasta 36 meses. Evite los ciclos de congelaci\u00f3n-descongelaci\u00f3n en el polvo. <strong>Procedimiento de reconstituci\u00f3n:<\/strong> inyectar agua bacteriost\u00e1tica por la pared lateral del vial de p\u00e9ptidos seg\u00fan el cuadro anterior. Agitar suavemente \u2014 no <strong>ajuste<\/strong> sacudir \u2014 y dejar reposar 5\u201310 minutos para su completa disoluci\u00f3n. La soluci\u00f3n debe ser transparente e incolora. <strong>Despu\u00e9s de la reconstituci\u00f3n:<\/strong> Conservar refrigerado a 2\u20138\u00a0\u00b0C y utilizar en un plazo de 30 d\u00edas. No congelar la soluci\u00f3n reconstituida. <\/p>\n<h2 id=\"faqs\">Preguntas frecuentes<\/h2>\n<h3>What is KPV used for in studies?<\/h3>\n<p>KPV is used in studies investigating anti-inflammatory biology, inflammatory bowel disease (IBD) and colitis, allergic inflammation, skin inflammation (eczema\/psoriasis models), wound-healing inflammation phase, joint inflammation, and comparative melanocortin pharmacology. It is <strong>ajuste<\/strong> FDA-approved and is sold here strictly for clinical studies use only. <\/p>\n<h3>\u00bfEn qu\u00e9 se diferencia KPV de Melanotan II o PT-141?<\/h3>\n<p>KPV es solo el fragmento C-terminal de tres amino\u00e1cidos de la alfa-MSH, mientras que Melanot\u00e1n II y PT-141 son an\u00e1logos completos o casi completos de la MSH c\u00edclica. Esto significa que KPV tiene <strong>ninguna actividad en los receptores de melanocortina<\/strong> y, por lo tanto, no tiene efectos sobre la pigmentaci\u00f3n (MC1R), la excitaci\u00f3n (MC4R) o el apetito (MC4R), solo actividad antiinflamatoria a trav\u00e9s de las v\u00edas NFkB y de los mastocitos. <\/p>\n<h3>What is the typical KPV dose?<\/h3>\n<p>Published preclinical protocols typically use 200\u2013500\u00a0mcg SC daily for systemic anti-inflammatory studies. Some IBD and skin-inflammation uses oral or topical administration. A 10\u00a0mg vial reconstituted with 2.0\u00a0mL bacteriostatic water yields 5\u00a0mg\/mL \u2014 10 ticks on a U-100 SC syringe delivers 500\u00a0mcg. <\/p>\n<h3>\u00bfEst\u00e1 KPV aprobado por la FDA?<\/h3>\n<p>No. KPV has not received FDA, EMA, or any regulatory approval. The full alpha-MSH peptide and KPV-related has informed melanocortin drug development broadly, but KPV itself remains. All KPV sold by peptide-studies suppliers is for clinical investigation only. <\/p>\n<h3>Can KPV be taken orally for IBD studies?<\/h3>\n<p>Yes. Unlike most peptides which are degraded by gastric enzymes, KPV retains some anti-inflammatory activity via the oral route in published IBD and colitis studies. This makes it unusually flexible for GI-inflammation studies where oral delivery targets the GI tract directly. Study protocols vary by model \u2014 SC remains the dominant systemic route. <\/p>\n<h3>\u00bfC\u00f3mo se debe almacenar KPV?<\/h3>\n<p>Viales liofilizados: refrigerados a 2\u20138\u00a0\u00b0C en el envase original, estable hasta 36 meses. Soluci\u00f3n reconstituida: refrigerada a 2\u20138\u00a0\u00b0C, utilizar en un plazo de 30 d\u00edas. No congelar la soluci\u00f3n reconstituida. <\/p>\n<h3>\u00bfC\u00f3mo reconstituyo KPV?<\/h3>\n<p>Sigue la tabla de reconstituci\u00f3n anterior. A\u00f1ade agua bacteriost\u00e1tica por la pared lateral del vial, agita suavemente y deja reposar entre 5 y 10 minutos para una disoluci\u00f3n completa. No <strong>ajuste<\/strong> agites. <\/p>\n<h3>Can KPV and BPC-157 be stacked in studies?<\/h3>\n<p>Yes \u2014 this is one of the most common studies combinations for GI and connective-tissue inflammation. KPV provides upstream NFkB-pathway anti-inflammatory signaling; <a href=\"https:\/\/medsbase.com\/es\/bpc-157\/\">BPC-157<\/a> proporciona actividad de reparaci\u00f3n tisular y factor de crecimiento en la v\u00eda VEGF. Los mecanismos son complementarios m\u00e1s que superpuestos. <\/p>\n<h3>\u00bfQu\u00e9 concentraciones tiene MedsBase en stock?<\/h3>\n<p>MedsBase ofrece KPV en viales liofilizados de 5 mg y 10 mg. Cada concentraci\u00f3n est\u00e1 disponible en tama\u00f1os de paquete de 10, 20 o 30 viales. Todos los viales se suministran con una pureza HPLC del 99%+ y un certificado de an\u00e1lisis bajo solicitud. <\/p>\n<h3>Does KPV cause side reported effects?<\/h3>\n<p>Published preclinical studies has reported a notably clean safety profile. Because KPV has no melanocortin-receptor activity, the pigmentation, arousal, and blood-pressure effects sometimes seen with full MC agonists do not occur with KPV. No significant off-target signals have been identified at typical doses. Long-term human safety data are not available. <\/p>\n<h3>\u00bfCu\u00e1l es la vida media de KPV?<\/h3>\n<p>KPV (Lys-Pro-Val) is a tripeptide with a short plasma half-life consistent with small unmodified peptides \u2014 estimated at under 30 minutes. Its primary application is gastrointestinal, where local delivery studies show effects on gut epithelial cells and immune cell populations that persist beyond plasma detection, attributed to direct receptor interaction at the intestinal mucosa. <\/p>\n<h3>How does KPV reduce inflammation in study models?<\/h3>\n<p>KPV es el trip\u00e9ptido C-terminal de \u03b1-MSH (hormona estimulante de melanocitos alfa) y retiene gran parte de la actividad antiinflamatoria del p\u00e9ptido parental mediante la activaci\u00f3n de MC1R. En modelos de colitis y lesi\u00f3n intestinal, KPV reduce la se\u00f1alizaci\u00f3n de NF-\u03baB, disminuye la producci\u00f3n de citocinas proinflamatorias (IL-1\u03b2, IL-6, TNF-\u03b1) y promueve la integridad de la barrera epitelial intestinal. Su peque\u00f1o tama\u00f1o facilita la captaci\u00f3n directa por las c\u00e9lulas epiteliales independientemente de las prote\u00ednas transportadoras. <\/p>\n<h3>\u00bfPuedo pedir KPV para env\u00edo internacional?<\/h3>\n<p>S\u00ed. MedsBase env\u00eda KPV a todo el mundo desde nuestra red de env\u00edo dedicada a p\u00e9ptidos. Los pedidos que solo contienen p\u00e9ptidos califican para nuestro servicio de env\u00edo independiente de p\u00e9ptidos. Los pedidos se env\u00edan en embalaje con control de temperatura y seguimiento completo. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Recovery and Performance<\/h2>\n<ul>\n<li><a href=\"\/es\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 tendon, ligament, gut recovery<\/li>\n<li><a href=\"\/es\/tb-500\/\"><strong>TB-500<\/strong><\/a> \u2014 Thymosin Beta-4 fragment \u2014 soft tissue and vascular recovery<\/li>\n<li><a href=\"\/es\/ipamorelin\/\"><strong>Ipamorelina<\/strong><\/a> \u2014 Agonista selectivo de grelina \u2014 pulso de GH limpio sin cortisol\/prolactina<\/li>\n<li><a href=\"\/es\/cjc-1295-with-dac\/\"><strong>CJC-1295 con DAC<\/strong><\/a> \u2014 An\u00e1logo de GHRH con vida media extendida<\/li>\n<li><a href=\"\/es\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 Copper peptide \u2014 skin and connective tissue regeneration<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Lecturas adicionales<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Learn the science behind this peptide<\/strong><\/p>\n<p style=\"margin: 0;\">Lee nuestra gu\u00eda completa basada en evidencia: <a href=\"https:\/\/medsbase.com\/es\/kpv-peptide-anti-inflammatory-guide\/\"><strong>KPV \u2014 the C-terminal alpha-MSH fragment for anti-inflammatory studies<\/strong><\/a>. Covers NFkB pharmacology, mast-cell stabilization, IBD studies history, oral and SC protocols, and stacking with BPC-157.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Favorece la reparaci\u00f3n tisular<br \/>\n\u2705 Reduce el estr\u00e9s oxidativo<br \/>\n\u2705 Modula la respuesta inmunitaria<br \/>\n\u2705 Promueve la resiliencia celular<br \/>\n\u2705 Mejora la integridad epitelial<\/p>\n<p><strong>KPV<\/strong> contiene compuesto de p\u00e9ptido sint\u00e9tico.<\/p>","protected":false},"featured_media":70964,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5472,5473],"class_list":["post-69013","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-kpv","product_tag-lysine-proline-valine","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product\/69013","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/comments?post=69013"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/media\/70964"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/media?parent=69013"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product_brand?post=69013"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product_cat?post=69013"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product_tag?post=69013"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}